Почетна › Рак плућа › Вирџинија › Arlington
Kliničke studije za Рак плућа u gradu Arlington, VA
42 studija za Рак плућа traži učesnike na lokacijama u gradu Arlington i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.
Zvanični tekst studije (na engleskom)
Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →
Substudy 01I: A Study of Investigational Agents in Participants With Previously Treated Stage IV Squamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01I/KEYMAKER-U01I)
Тражи се учесникФаза 2
- Virginia Cancer Specialists (VCS) ( Site 0408), Fairfax · 11 ми удаљено
BL-M14D1 Plus Atezolizumab vs Standard of Care in First-Line Extensive-Stage Small Cell Lung Cancer (BrenDeLL-Lung01)
Тражи се учесникФаза 3
- Virginia Cancer Specialists, Fairfax · 11 ми удаљено
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Тражи се учесникФаза 3
- Kaiser Permanente Tysons Corner Medical Center, McLean · 5 ми удаљено
A Phase 1 Dose Escalation and Dose Expansion Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
Тражи се учесникФаза 1
- NEXT Virginia, Fairfax · 11 ми удаљено
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
Тражи се учесникФаза 1/2
- Virginia Cancer Specialists, Fairfax · 11 ми удаљено
The Vanguard Study: Testing a New Way to Screen for Cancer
Тражи се учесникЗдраве особе су добродошле
- Inova Schar Cancer Institute, Fairfax · 11 ми удаљено
- Inova Fair Oaks Hospital, Fairfax · 11 ми удаљено
Phase 1 Study of PF-08046033 in Advanced Solid Tumors
Тражи се учесникФаза 1
- Inova Schar Cancer Infusion Pharmacy, Fairfax · 11 ми удаљено
- Inova Schar Cancer, Fairfax · 11 ми удаљено
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
Тражи се учесникФаза 1
- Inova Schar Cancer Institute, Falls Church · 4 ми удаљено
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Тражи се учесникФаза 3
- USO - Virginia Cancer Specialists, Fairfax · 11 ми удаљено
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer (ROSETTA Lung-02)
Тражи се учесникФаза 2/3
- Inova Schar Cancer, Fairfax · 11 ми удаљено
- Virginia Cancer Specialists, Fairfax · 11 ми удаљено
Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations
Тражи се учесникФаза 3
- Virginia Cancer Specialists, Fairfax · 11 ми удаљено
Study to Evaluate Sutetinib Maleate Capsule in Locally Advanced or Metastatic Non-small Cell Lung Cancer
Тражи се учесникФаза 2
- Virginia Cancer Specialists, Fairfax · 11 ми удаљено
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
Тражи се учесникФаза 1
- Research Site, Fairfax · 11 ми удаљено
Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients
Тражи се учесникФаза 1/2
- NEXT Oncology, Fairfax · 11 ми удаљено
Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
Тражи се учесникФаза 2
- Research Site, Fairfax · 11 ми удаљено
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
Тражи се учесникФаза 1/2
- NEXT Virginia, Fairfax · 11 ми удаљено
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
Тражи се учесникФаза 1/2
- Virginia Cancer Specialists, Fairfax · 11 ми удаљено
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
Тражи се учесникФаза 1/2
- NEXT Oncology Virginia, Fairfax · 11 ми удаљено
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
Тражи се учесникФаза 1/2
- Avenzo Therapeutics Recruiting Site, Fairfax · 11 ми удаљено
Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
Тражи се учесникФаза 3
- Virginia Cancer Specialists, Fairfax · 11 ми удаљено
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Тражи се учесникФаза 1/2
- NEXT Virginia, Fairfax · 11 ми удаљено
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
Тражи се учесникФаза 1
- Virginia Cancer Specialists, Fairfax · 11 ми удаљено
A Study to Assess Zipalertinib Versus Placebo in Participants With Early Stage NSCLC With Uncommon EGFR Mutations, Following Complete Tumor Resection
Тражи се учесникФаза 3
- Virginia Cancer Specialists - Arlington Office, Arlington
- Virginia Cancer Specialists - Fairfax Office, Fairfax · 11 ми удаљено
- Virginia Cancer Specialists - Reston, Reston · 14 ми удаљено
- и још 1
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Тражи се учесникФаза 2
- Kaiser Permanente Tysons Corner Medical Center, McLean · 5 ми удаљено
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Тражи се учесникФаза 2/3
- Kaiser Permanente Tysons Corner Medical Center, McLean · 5 ми удаљено
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Тражи се учесникФаза 1/2
- Virginia Cancer Specialists, Fairfax · 11 ми удаљено
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
Тражи се учесникФаза 3
- Virginia Cancer Specialists, Fairfax · 11 ми удаљено
A Study of PHN-012 in Patients With Advanced Solid Tumors
Тражи се учесникФаза 1
- PHN-012-001 Site, Fairfax · 11 ми удаљено
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Тражи се учесникФаза 1/2
- NEXT Oncology Virginia, Fairfax · 11 ми удаљено
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
Тражи се учесникФаза 1/2
- Next Oncology Virginia Cancer Specialist, Fairfax · 11 ми удаљено
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
Тражи се учесникФаза 1
- NEXT - Virginia, Fairfax · 11 ми удаљено
Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer
Тражи се учесникФаза 1
- NEXT Oncology, Fairfax · 11 ми удаљено
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
Тражи се учесникФаза 3
- Inova Schar Cancer Institute, Fairfax · 11 ми удаљено
- Inova Fair Oaks Hospital, Fairfax · 11 ми удаљено
Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors
Тражи се учесникФаза 1
- NEXT Oncology - Virginia Cancer Specialists, Fairfax · 11 ми удаљено
A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
Тражи се учесникФаза 1/2
- NEXT Virginia, Fairfax · 11 ми удаљено
Study of NXP900 With Osimertinib in Subjects With Advanced, EGFR-Mutated Non-Small Cell Lung Cancer
Тражи се учесникФаза 1
- NEXT Virginia, Fairfax · 11 ми удаљено
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
Тражи се учесникФаза 1
- NEXT Oncology Virginia, Fairfax · 11 ми удаљено
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Тражи се учесникФаза 2
- Kaiser Permanente Tysons Corner Medical Center, McLean · 5 ми удаљено
A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies
Тражи се учесникФаза 1/2
- NEXT Virginia, Fairfax · 11 ми удаљено
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
Тражи се учесникФаза 1/2
- Next Oncology Virginia, Fairfax · 11 ми удаљено
A Study of LP-300 With Carboplatin and Pemetrexed in Never Smokers With Advanced Lung Adenocarcinoma
Тражи се учесникФаза 2
- Inova Fairfax Hospital, Fairfax · 11 ми удаљено
A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors
Тражи се учесникФаза 1
- NEXT Virginia, Fairfax · 11 ми удаљено
Studije za Рак плућа u drugim gradovima
- Houston, TX78 студија
- Boston, MA63 студија
- New York City, NY60 студија
- Los Angeles, CA45 студија
- Chicago, IL43 студија
- Washington, DC41 студија
- Baltimore, MD41 студија
- Nashville, TN39 студија
- St. Louis, MO37 студија
- Columbus, OH36 студија
- Philadelphia, PA36 студија
- Seattle, WA34 студија
Ostale studije u gradu Arlington
- Немалоклетни карцином плућа111 студија
- Колоректални карцином54 студија
- Метастатски карцином52 студија
- Рак (све врсте)52 студија
- Рак дојке50 студија
- Рак јајника47 студија
- Карцином ендометријума41 студија
- Рак панкреаса33 студија
- Плоскоклеточни карцином главе и врата29 студија
- Sitnoćelijski rak pluća22 студија
- Trostruko negativni rak dojke21 студија
- Рак желуца21 студија
Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.